Evaluating the effects of PEGylated growth hormone on short stature in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the long-term safety and effectiveness of polyethylene glycol-recombinant human growth hormone (PEG-rhGH) in treating growth disorders in children, including growth hormone deficiency and idiopathic short stature. It involves a retrospective analysis of treatment outcomes and factors influencing efficacy, followed by prospective monitoring. Data collected will be uploaded to the Global Registry of New Therapies for Rare Endocrine Diseases and Bone Disorders (GloBE-Reg) to enhance understanding of real-world PEG-GH treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients with endogenous growth hormone deficiency, Turner Syndrome, SGA, idiopathic short stature, etc. treated with polyethylene glycol recombinant human growth hormone injection

Exclusion Criteria:

Patients with serious heart and lung, blood system, malignant tumors and other diseases or systemic infections, immune function is low and Persons with mental illness;

Where it's running

• Department of Endocrinology, Genetics, Metabolism
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Principal investigator: Bingyan Cao, Dr. — Beijing Children's Hospital
• Study coordinator: Chunxiu Gong, Dr.
• Email: chunxiugong@163.com
• Phone: 13370115001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two doses of growth hormone in children with growth deficiency

  This study is testing whether a higher or lower dose of growth hormone helps children with growth deficiency grow taller and stay safe during treatment.

  Recruiting Phase 3 Northwell Health · New York, New York · NCT06103513

• Exploring how iron deficiency anemia affects child development in young children

  This study looks at how iron deficiency anemia affects the development of young children between 6 to 24 months old, focusing on their motor skills, language, and social behavior.

  Recruiting Pingshan District Maternal & Child Healthcare Hospital of Shenzhen · Shenzhen, China/Guangdong · NCT06662045

• Identifying genetic causes of growth and puberty disorders

  This study is trying to find new genetic changes that might cause growth and puberty disorders by looking at blood samples from patients with these conditions.

  Recruiting Fondation Ophtalmologique Adolphe de Rothschild · Paris · NCT03283852

• Network for monitoring children's growth and obesity

  This study is testing a new way for doctors to track children's growth and weight to help spot any problems early and provide better care.

  Recruiting University of Leipzig · Leipzig, Saxony · NCT03072537

• Understanding growth hormone deficiency after a brain injury in adults

  This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.

  Recruiting University of Calgary · Calgary, Alberta and 1 other locations · NCT07795736

• Belgians and Luxembourgians with childhood GHD: adult outcomes and follow-up

  This study tests how adults who had childhood-onset growth hormone deficiency and were treated with rhGH fare in follow-up and ongoing treatment.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Brussels, Woluwe-saint-lambert · NCT06694506

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.